Biotech NewsGossamer Bio (GOSS) Wins $10 Price Target BioTech Health XSeptember 15, 2025 Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for… 0 Shares 0 0 0 0 0 0 0